Journal of Medicinal Chemistry p. 7936 - 7949 (2016)
Update date:2022-08-15
Topics:
McGowan, David
Herschke, Florence
Pauwels, Frederik
Stoops, Bart
Last, Stefaan
Pieters, Serge
Scholliers, Annick
Thoné, Tine
Van Schoubroeck, Bertrand
De Pooter, Dorien
Mostmans, Wendy
Khamlichi, Mourad Daoubi
Embrechts, Werner
Dhuyvetter, Deborah
Smyej, Ilham
Arnoult, Eric
Demin, Samu?l
Borghys, Herman
Fanning, Gregory
Vlach, Jaromir
Raboisson, Pierre
Toll-like receptor (TLR) 7 and 8 agonists can potentially be used in the treatment of viral infections and are particularly promising for chronic hepatitis B virus (HBV) infection. An internal screening effort identified a pyrimidine Toll-like receptor 7 and 8 dual agonist. This provided a novel alternative over the previously reported adenine and pteridone type of agonists. Structure-activity relationship, lead optimization, in silico docking, pharmacokinetics, and demonstration of ex vivo and in vivo cytokine production of the lead compound are presented.
View MoreContact:+86-571-86491666
Address:SHI XIANG ROAD
Contact:+86-533-3112891
Address:zibo
Fujian Huitian Biological Pharmacy Co., Ltd.
Contact:0086-598-8300831; 8339920
Address:No.46,Taijiang Road,Sanming City,Fujian,China
Angelisun(Chongqing) Pharmaceutical Co., LTD.
Contact:+86-23-68030926-816
Address:D1-7 Tech & Entrepreneurs Park, Kecheng Road, Erlang Hi-Tech Areas, Chongqing, China
Lonzeal Pharmaceuticals Co., Ltd.
website:http://www.lonzeal.com
Contact:+86-13381011962
Address:RM 801, Yue MOMA, No. 26 Anningzhuang Rd. Haidian District, Beijing, China
Doi:10.1021/ja00155a010
(1995)Doi:10.1002/hlca.19920750610
(1992)Doi:10.1039/c4ra02384f
(2014)Doi:10.1021/jm030897l
(2004)Doi:10.1021/ic401261z
(2013)Doi:10.1021/acs.orglett.8b00016
(2018)